FDA Reviews Samsung Bioepis’ Bevacizumab

Avastin Rival Will Be Sold Through Merck, Sharp & Dohme

 
• By David Wallace
  
Accepted_Stamp
Samsung Bioepis’ Bevacizumab Filing Has Been Accepted By The FDA • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products